Lipogenesis
Concept
Vocabulary Service
Overview
subject area of
-
AMPK
β1 reduces tumor progression and improves survival in p53 null mice Academic Article
-
AMP-activated protein kinase, fatty acid metabolism, and insulin sensitivity Academic Article
-
AMPK activation by SC4 inhibits noradrenaline-induced lipolysis and insulin-stimulated lipogenesis in white adipose tissue Academic Article
-
An AMP-activated protein kinase–stabilizing peptide ameliorates adipose tissue wasting in cancer cachexia in mice Academic Article
-
Bacterial lipids Academic Article
-
Diacylglycerol Kinase Delta Promotes Lipogenesis Academic Article
-
Diacylglycerol kinase epsilon suppresses expression of p53 and glycerol kinase in mouse embryo fibroblasts Academic Article
-
Direct AMPK Activation Corrects NASH in Rodents Through Metabolic Effects and Direct Action on Inflammation and Fibrogenesis Academic Article
-
Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human Academic Article
-
Effects of PKB/Akt inhibitors on insulin-stimulated lipogenesis and phosphorylation state of lipogenic enzymes in white adipose tissue Academic Article
-
Enhanced activation of cellular AMPK by dual-small molecule treatment: AICAR and A769662 Academic Article
-
Fetal and neonatal exposure to nicotine leads to augmented hepatic and circulating triglycerides in adult male offspring due to increased expression of fatty acid synthase Academic Article
-
GDF10 blocks hepatic PPARγ activation to protect against diet-induced liver injury Academic Article
-
Increased incidence of non-alcoholic fatty liver disease in male rat offspring exposed to fluoxetine during fetal and neonatal life involves the NLRP3 inflammasome and augmented de novo hepatic lipogenesis Academic Article
-
Inhibition of Acetyl-CoA Carboxylase by Phosphorylation or the Inhibitor ND-654 Suppresses Lipogenesis and Hepatocellular Carcinoma Academic Article
-
Lipogenesis inhibitors: therapeutic opportunities and challenges Academic Article
-
Liver-specific suppressor of cytokine signaling-3 deletion in mice enhances hepatic insulin sensitivity and lipogenesis resulting in fatty liver and obesity1 Academic Article
-
Loss of TDAG51 Results in Mature-Onset Obesity, Hepatic Steatosis, and Insulin Resistance by Regulating Lipogenesis Academic Article
-
Maternal Nicotine Exposure Leads to Augmented Expression of the Antioxidant Adipose Tissue Triglyceride Lipase Long-Term in the White Adipose of Female Rat Offspring Academic Article
-
Mechanism of Action of Compound-13: An α1-Selective Small Molecule Activator of AMPK Academic Article
-
Metformin and salicylate synergistically activate liver AMPK, inhibit lipogenesis and improve insulin sensitivity Academic Article
-
PPARδ activation attenuates hepatic steatosis in Ldlr mice by enhanced fat oxidation, reduced lipogenesis, and improved insulin sensitivity Academic Article
-
Salicylate activates AMPK and synergizes with metformin to reduce the survival of prostate and lung cancer cells ex vivo through inhibition of de novo lipogenesis Academic Article
-
Salicylate enhances the response of prostate cancer to radiotherapy Academic Article
-
Salicylate improves macrophage cholesterol homeostasis via activation of Ampk Academic Article
-
Salsalate (Salicylate) Uncouples Mitochondria, Improves Glucose Homeostasis, and Reduces Liver Lipids Independent of AMPK-β1 Academic Article
-
Statins Promote Interleukin-1β–Dependent Adipocyte Insulin Resistance Through Lower Prenylation, Not Cholesterol Academic Article
-
The SGLT2 inhibitor canagliflozin suppresses lipid synthesis and interleukin-1 beta in ApoE deficient mice Academic Article
-
Western diet consumption through early life induces microvesicular hepatic steatosis in association with an altered metabolome in low birth weight Guinea pigs Academic Article